Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Acta Clinica Belgica|April 14, 2011
PARP inhibitors in oncology: a new synthetic lethal approach to cancer therapyV Kruse, S Rottey, O De Backer, et al.
Acta Clinica Belgica|June 9, 2016
Incorporating PARP-inhibitors into clinical routine: A tailored treatment strategy to tackle ovarian cancerE De Jaeghere, K Vandecasteele, K Claes, et al.
Nuklearmedizin. Nuclear Medicine|August 8, 2014
CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curveV Kruse, C Van de Wiele, M Borms, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 4, 2014
Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution withinV Kruse, G Mees, A Maes, et al.
Acta Clinica Belgica|December 7, 2010
Cardiac toxicity of trastuzumab: experience at the Ghent Unversity Hospital, BelgiumC Lamot, S Rottey, T De Backer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Iodine-labeled tamoxifen uptake in primary human breast carcinomaC Van de Wiele, V Cocquyt, R VandenBroecke, et al.
Acta Chirurgica Belgica|February 27, 2009
The role of oncoplastic surgery in breast cancerM Hamdi, Y Sinove, H DePypere, et al.
Acta Clinica Belgica|May 13, 2009
Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authoritiesI Van Vlaenderen, J L Canon, V Cocquyt, et al.
European Journal of Nuclear Medicine|December 6, 2000
Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility studyC Van de Wiele, F Dumont, R Vanden Broecke, et al.
European Journal of Cancer (Oxford, England : 1990)|November 20, 2010
Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952M G Bouwhuis, S Suciu, W Kruit, et al.
Pageof 3